Healthcare
Sunday, September 11, 2016
BRIEF-BeiGene receives approval to initiate clinical trials in China with PD-1 antibody BGB-A317
* Beigene Receives Approval To Initiate Clinical Trials In
China With Pd-1 antibody bgb-a317
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment